Killing pancreatic cancer with T cells that supercharge themselves
Scientists at UC San Francisco (UCSF) have engineered T cells to produce a potent anti-cancer cytokine, but only when they encounter tumor cells. The immunotherapy eliminated melanoma and pancreatic cancer in mice without major side effects, and it offers a promising new strategy for fighting these and other hard-to-treat cancers.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
More News: Cancer | Cancer & Oncology | Immunotherapy | Melanoma | Pancreas | Pancreatic Cancer | Pharmaceuticals | Skin Cancer